Share
Latest News
What You Need to Know About Johnson & Johnson's 2018 Third-Quarter Earnings
What You Need to Know About Johnson & Johnson's 2018 Third-Quarter Earnings
Share
Learn how the company's Consumer, Medical Devices and Pharmaceutical businesses performed in the third quarter of 2018 in this snapshot of its latest earnings report.

Johnson & Johnson made several key financial announcements this morning about its third-quarter performance in 2018:

  • Company sales in the third quarter totaled $20.3 billion—up 3.6% over last quarter
  • The adjusted diluted earnings per share was $2.05, reflecting a 7.9% increase
  • The company registered growth in its Consumer and Pharmaceutical sectors around the globe. Its Pharmaceutical business, for example, reported a worldwide sales increase of 6.7% in the third quarter

Check out this infographic for more details about the company's third-quarter 2018 results, and read a message from Alex Gorsky Alex Gorsky,Chairman and Chief Executive Officer, Johnson & Johnson, Chairman and Chief Executive Officer, Johnson & Johnson.


Share expand

Read the earnings press release, which includes full financial data for the third quarter of the year.

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue